← back to search

David E. Newby

University of Newcastle Australia · AU
Area of research
Radiology, Nuclear Medicine and Imaging · Cardiology and Cardiovascular Medicine
Research interest
Background: Sport and exercise medicine (SEM) is a multidisciplinary field that integrates expertise from various healthcare professionals to optimise athletic performance and promote physical activity for chronic disease prevention and management. Australian pharmacists are well-positioned to contribute to SEM, yet their roles remain undefined beyond niche areas like anti-doping. Interdisciplinary collaboration, particularly with physiotherapists, is also underexplored. This study investigates pharmacists' engagement in SEM and pharmacist-physiotherapist collaboration, using the Capability, Opportunity, Motivation¿Behaviour (COM[sbnd]B) model to explore behavioural components.
h-index
132
citations
69,097
works
1,585
NIH funding
primary concept
email

Recent publications

Invasive vs Conservative Strategy for Frail Older Patients With Myocardial Infarction
JAMA Network Open 2026cited by 1position: middledoi
Coronary CT angiography-guided management of patients with stable chest pain: 10-year outcomes from the SCOT-HEART randomised controlled trial in Scotland
The Lancet 2025cited by 74position: middledoi
Coronary CT angiography evaluation with artificial intelligence for individualized medical treatment of atherosclerosis: a Consensus Statement from the QCI Study Group
Nature Reviews Cardiology 2025cited by 27position: middledoi
Impact of diabetes mellitus on coronary artery plaque characteristics and outcomes in the SCOT-HEART trial
Journal of cardiovascular computed tomography 2025cited by 11position: middledoi
Gene therapy in cardiac and vascular diseases: a review of approaches to treat genetic and common cardiovascular diseases with novel gene-based therapeutics
Cardiovascular Research 2025cited by 10position: middledoi
Machine learning to optimize use of natriuretic peptides in the diagnosis of acute heart failure
European Heart Journal Acute Cardiovascular Care 2025cited by 2position: middledoi
Prevention of Adverse Cardiovascular Events Using the 23-Valent Pneumococcal Polysaccharide Vaccine: A Randomized Clinical Trial.
2025cited by 0position: selecteddoi
First-in-human controlled inhalation of thin graphene oxide nanosheets to study acute cardiorespiratory responses
Nature Nanotechnology 2024cited by 74position: middledoi
Personalized Intervention Based on Early Detection of Atherosclerosis
Journal of the American College of Cardiology 2024cited by 64position: middledoi
Aortic Valve Replacement vs Clinical Surveillance in Asymptomatic Severe Aortic Stenosis
Journal of the American College of Cardiology 2024cited by 60position: middledoi
Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression
JAMA Cardiology 2024cited by 53position: middledoi
Environmentally Not So Friendly: Global Warming, Air Pollution, and Wildfires
Journal of the American College of Cardiology 2024cited by 38position: middledoi
Rationale and design of the early valve replacement in severe asymptomatic aortic stenosis trial
American Heart Journal 2024cited by 22position: middledoi
Uniform or Sex-Specific Cardiac Troponin Thresholds to Rule Out Myocardial Infarction at Presentation
Journal of the American College of Cardiology 2024cited by 12position: middledoi
Water, Soil, Noise, and Light Pollution
Journal of the American College of Cardiology 2024cited by 10position: middledoi
Computed tomographic angiography measures of coronary plaque in clinical trials: opportunities and considerations to accelerate drug translation
Frontiers in Cardiovascular Medicine 2024cited by 6position: middledoi
Machine learning for diagnosis of myocardial infarction using cardiac troponin concentrations
Nature Medicine 2023cited by 148position: middledoi
Clinical quantitative coronary artery stenosis and coronary atherosclerosis imaging: a Consensus Statement from the Quantitative Cardiovascular Imaging Study Group
Nature Reviews Cardiology 2023cited by 110position: middledoi
Deep-Learning for Epicardial Adipose Tissue Assessment With Computed Tomography
JACC. Cardiovascular imaging 2023cited by 100position: middledoi
Roadmap on the use of artificial intelligence for imaging of vulnerable atherosclerotic plaque in coronary arteries
Nature Reviews Cardiology 2023cited by 95position: middledoi
National Trends in Coronary Artery Disease Imaging
JACC. Cardiovascular imaging 2023cited by 68position: middledoi
Somatostatin Receptor PET/MR Imaging of Inflammation in Patients With Large Vessel Vasculitis and Atherosclerosis
Journal of the American College of Cardiology 2023cited by 65position: middledoi
Multi-modality imaging in aortic stenosis: an EACVI clinical consensus document
European Heart Journal - Cardiovascular Imaging 2023cited by 62position: middledoi
Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials
The Lancet Neurology 2023cited by 61position: middledoi
Implementation of a high sensitivity cardiac troponin I assay and risk of myocardial infarction or death at five years: observational analysis of a stepped wedge, cluster randomised controlled trial
BMJ 2023cited by 16position: middledoi
Persistence of Detectable Anti-Pneumococcal Antibodies 4 Years After Pneumococcal Polysaccharide Vaccination in a Randomised Controlled Trial: The Australian Study for the Prevention through Immunisation of Cardiovascular Events (AUSPICE).
2023cited by 4position: selecteddoi
Pericoronary Adipose Tissue Attenuation, Low-Attenuation Plaque Burden, and 5-Year Risk of Myocardial Infarction
JACC. Cardiovascular imaging 2022cited by 152position: middledoi
Development and validation of a decision support tool for the diagnosis of acute heart failure: systematic review, meta-analysis, and modelling study
BMJ 2022cited by 60position: middledoi
Influence of Age on the Diagnosis of Myocardial Infarction
Circulation 2022cited by 44position: middledoi
Validation of the myocardial-ischaemic-injury-index machine learning algorithm to guide the diagnosis of myocardial infarction in a heterogenous population: a prespecified exploratory analysis
The Lancet Digital Health 2022cited by 38position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

David Newby · University of Newcastle Australia35 papers (2019–2025)Marc R. Dweck · Vanderbilt University Medical Center19 papers (2014–2025)Nicholas L. Mills · Edinburgh Royal Infirmary18 papers (2012–2025)Anoop Shah · Rutgers, The State University of New Jersey12 papers (2018–2025)Robert D. Brook · Wayne State University11 papers (2014–2021)Michelle C. Williams · British Heart Foundation Centre for Research Excellence11 papers (2020–2025)Courtney Crim · Cambridge University Hospitals NHS Foundation Trust9 papers (2016–2021)Jørgen Vestbo · Manchester Academic Health Science Centre9 papers (2016–2021)Fernando J. Martínez · University of Massachusetts Chan Medical School9 papers (2016–2021)Philip D Adamson · Christchurch Clinical Studies Trust9 papers (2018–2025)Peter M.A. Calverley · University of Liverpool9 papers (2016–2021)Bartolomé R. Celli · Harvard University9 papers (2016–2021)Julie Yates · UK Health Security Agency9 papers (2016–2021)Mark R. Miller · World Heart Federation9 papers (2012–2024)Julie A. Anderson · Medical University of South Carolina9 papers (2016–2021)Damini Dey · St. Vincent's Hospital8 papers (2018–2025)Tania Pawade · Monash Health7 papers (2018–2021)Mhairi Doris · University of Edinburgh7 papers (2018–2021)Edward Nicol · King's College London7 papers (2020–2025)Piotr J. Slomka · Norwegian Womens Public Health Association6 papers (2018–2025)